Self‐expandable sirolimus‐eluting stents compared to second‐generation drug‐eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS‐2 registries
Sign Up to like & getrecommendations! Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27809
Abstract: To compare the effectiveness and safety of self‐expandable, sirolimus‐eluting Stentys stents (SES) and second‐generation drug‐eluting stents (DES‐II) for the treatment of the unprotected left main (ULM). read more here.
Keywords: self expandable; eluting stents; expandable sirolimus; sirolimus eluting ... See more keywords
One‐year clinical outcome of biodegradable polymer sirolimus‐eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry
Sign Up to like & getrecommendations! Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28305
Abstract: The ULISSE registry has demonstrated the real‐world performance of the Ultimaster biodegradable polymer sirolimus‐eluting stent (BP‐SES) in a large cohort of patients undergoing percutaneous coronary intervention, including a large proportion of patients presenting with acute… read more here.
Keywords: polymer sirolimus; biodegradable polymer; patients presenting; sirolimus eluting ... See more keywords
One‐year clinical outcome of biodegradable polymer sirolimus‐eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry)
Sign Up to like & getrecommendations! Published in 2020 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28694
Abstract: The ULISSE registry evaluated the real‐world performance of the Ultimaster® biodegradable polymer sirolimus‐eluting stent (BP‐SES) in a multicenter‐independent cohort of patients undergoing percutaneous coronary intervention, including a large proportion of diabetes mellitus (DM) patients. read more here.
Keywords: polymer sirolimus; biodegradable polymer; sirolimus eluting; ulisse registry ... See more keywords
First‐in‐man study of a thinner‐strut sirolimus‐eluting bioresorbable scaffold (FUTURE‐I): Three‐year clinical and imaging outcomes
Sign Up to like & getrecommendations! Published in 2020 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28722
Abstract: The FUTURE‐I study aimed to assess preliminary safety and effectiveness with the long‐term clinical and imaging follow‐up for the Firesorb (MicroPort, Shanghai, China), a thinner‐strut sirolimus‐eluting bioresorbable scaffold (BRS). read more here.
Keywords: strut sirolimus; thinner strut; bioresorbable scaffold; sirolimus eluting ... See more keywords
Healing and early stent coverage after ultrathin strut biodegradable polymer‐coated sirolimus‐eluting stent implantation: SiBi optical coherence tomography study
Sign Up to like & getrecommendations! Published in 2020 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29371
Abstract: The aim of SiBi study was to evaluate the early vascular healing and neointimal coverage after implantation of ultrathin (60 μm) biodegradable polymer‐coated Tetriflex (Sahajanand Medical Technologies Pvt. Ltd., Surat, India) sirolimus‐eluting stent (SES) using optical… read more here.
Keywords: polymer coated; eluting stent; implantation; sirolimus eluting ... See more keywords
Nine‐month angiographic and 2‐year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus‐eluting COMBO dual‐therapy stent versus a polymer‐free sirolimus‐eluting stent in Chinese patients
Sign Up to like & getrecommendations! Published in 2021 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29553
Abstract: We evaluated the safety and efficacy of the novel dual‐therapy sirolimus‐eluting and endothelial progenitor cell (EPC) capture COMBO stent. read more here.
Keywords: dual therapy; sirolimus; sirolimus eluting; nine month ... See more keywords
Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
Sign Up to like & getrecommendations! Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30175
Abstract: To compare the efficacy and safety of the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent (DTS) and the sirolimus‐eluting Orsiro stent (SES) in patients with and without diabetes mellitus (DM) included in the Scandinavian Organization… read more here.
Keywords: cd34 antibody; dual therapy; stent; antibody covered ... See more keywords
Serum Sirolimus Levels After Implantation of Third Generation Drug Eluting Cobalt Chromium Coronary Stent in Ductus Arteriosus in Neonates with Duct-Dependent Pulmonary Circulation
Sign Up to like & getrecommendations! Published in 2020 at "Pediatric Cardiology"
DOI: 10.1007/s00246-020-02381-4
Abstract: Ductal stenting (DS) palliates duct-dependent lesions using coronary stents. Sirolimus-eluting stents have replaced bare-metal stents in coronary interventions. Concerns exist about sirolimus levels in neonates. Therapeutic immunosuppressive sirolimus level is 5–15 ng/ml. After neonatal DS, drug… read more here.
Keywords: sirolimus levels; drug; sirolimus eluting; stent ... See more keywords
Open-labeled randomized controlled trial to evaluate the 1-year clinical outcomes of polymer-free sirolimus-eluting coronary stents as compared with biodegradable polymer-based sirolimus-eluting coronary stents
Sign Up to like & getrecommendations! Published in 2018 at "Indian Heart Journal"
DOI: 10.1016/j.ihj.2018.08.015
Abstract: Background Head to head trials of clinical outcomes of sirolimus eluting polymer free vs. biodegradable polymer stents are lacking. Methods Single centre prospective open labeled randomised controlled clinical trial. Basis for sample size calculation was… read more here.
Keywords: biodegradable polymer; year; polymer; eluting coronary ... See more keywords
TCTAP A-155 One-year Clinical Outcomes of Biodegradable Polymer Coated Sirolimus-eluting Coronary Stent System in Patients with Coronary Artery Disease
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2017.03.201
Abstract: The biodegradable polymer-coated Sirolimus-eluting Coronary Stent (SES) System for the treatment of coronary artery diseases has resulted in substantial improvements in real-life scenario. To evaluate the safety and performance of Metafor Sirolimus-eluting Coronary Stent System… read more here.
Keywords: system; biodegradable polymer; eluting coronary; sirolimus eluting ... See more keywords
LONG TERM CLINICAL OUTCOME OF A NOVEL SIROLIMUS-ELUTING CORONARY STENT WITH UNIQUE COATING TECHNOLOGY IN PATIENTS WITH DIABETES
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(19)31764-4
Abstract: The Aim of the en-ABL e-registry is to evaluate safety and efficacy of ABLUMINUS DES (Sirolimus Eluting Stent) in diabetic patients vs. non diabetic patients. The en-ABL e-registry is a prospective, real world, all-comers, multicenter… read more here.
Keywords: clinical outcome; term clinical; outcome novel; long term ... See more keywords